Sullivan Christopher Blake, Andresen Nicholas S, Kendell Nicholas, Al-Qurayshi Zaid, Pagedar Nitin A
1 University of Iowa, Iowa City, IA, USA.
2 Johns Hopkins University, Baltimore, MD, USA.
Ann Otol Rhinol Laryngol. 2019 Oct;128(10):949-955. doi: 10.1177/0003489419848786. Epub 2019 May 15.
Survival outcomes for advanced non-melanoma skin cancers of the head and neck treated with surgical resection are not well described in the literature. We aimed to describe outcomes for T3 and T4 cutaneoous squamous cell carcinoma of the head or neck treated with surgical resection at 1 tertiary academic medical center.
We analyzed a retrospective cohort of patients diagnosed with T3 or T4 cutaneous squamous cell carcinoma (SCC) of the head or neck from 2005 to 2016 treated with definitive surgical resection. Survival outcomes were examined using Kaplan-Meier analysis, and multivariate analysis was completed with Cox proportional hazard model.
Forty-three patients met inclusion criteria. The mean age at diagnosis was 74.7 years (SD = 10.2), and 34 (79.1%) patients were male. Twelve (27.9%) patients were immunosuppressed. Radical resection, defined as temporal bone resection, orbital exenteration, calvarial resection, mandibulectomy, or maxillectomy, was performed in 25 (58.1%) cases. Final surgical margins were positive in 19 (44.2%) cases. Patients with tumors of the scalp/neck had a 1-year survival probability of 85.7%, and the probability of survival 1 year after a neck dissection was greater than 93%.
Anatomical subsites, specifically scalp/neck tumors, tended to have worse overall survival. Positive final margins tended to indicate a worse prognosis, and overall survival and recurrence were not significantly different among patients who underwent radical surgical resection compared to soft tissue resection.
手术切除治疗的头颈部晚期非黑色素瘤皮肤癌的生存结果在文献中描述不足。我们旨在描述在一家三级学术医疗中心接受手术切除治疗的头颈部T3和T4皮肤鳞状细胞癌的结果。
我们分析了2005年至2016年确诊为头颈部T3或T4皮肤鳞状细胞癌(SCC)并接受根治性手术切除的患者的回顾性队列。使用Kaplan-Meier分析检查生存结果,并使用Cox比例风险模型完成多变量分析。
43例患者符合纳入标准。诊断时的平均年龄为74.7岁(标准差 = 10.2),34例(79.1%)患者为男性。12例(27.9%)患者免疫抑制。25例(58.1%)患者进行了根治性切除,定义为颞骨切除、眶内容摘除术、颅骨切除、下颌骨切除术或上颌骨切除术。19例(44.2%)患者的最终手术切缘为阳性。头皮/颈部肿瘤患者的1年生存概率为85.7%,颈部清扫术后1年的生存概率大于93%。
解剖亚部位,特别是头皮/颈部肿瘤,总体生存率往往较差。最终切缘阳性往往预示预后较差,与软组织切除相比,接受根治性手术切除的患者的总体生存率和复发率无显著差异。